Dalal Aldeghaither

889 total citations
12 papers, 643 citations indexed

About

Dalal Aldeghaither is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Dalal Aldeghaither has authored 12 papers receiving a total of 643 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Immunology. Recurrent topics in Dalal Aldeghaither's work include Monoclonal and Polyclonal Antibodies Research (6 papers), CAR-T cell therapy research (5 papers) and Immunotherapy and Immune Responses (3 papers). Dalal Aldeghaither is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), CAR-T cell therapy research (5 papers) and Immunotherapy and Immune Responses (3 papers). Dalal Aldeghaither collaborates with scholars based in United States, Saudi Arabia and Switzerland. Dalal Aldeghaither's co-authors include Louis M. Weiner, Brandon G. Smaglo, Elizabeth Hill, Jason M. Redman, Allison O’Connell, David J. Zahavi, Norah Almusharraf, Mohammad Nurunnabi, Simon P. Fletcher and Stephan Menne and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Hepatology and PLoS Pathogens.

In The Last Decade

Dalal Aldeghaither

12 papers receiving 629 citations

Peers

Dalal Aldeghaither
Suzanne L. Kirby United States
Bei Wang United States
Xun Zeng China
Bridget P. Keenan United States
Li-Chung Tsao United States
Zhigang Xie Singapore
Elizabeth C. Richards United States
Suzanne L. Kirby United States
Dalal Aldeghaither
Citations per year, relative to Dalal Aldeghaither Dalal Aldeghaither (= 1×) peers Suzanne L. Kirby

Countries citing papers authored by Dalal Aldeghaither

Since Specialization
Citations

This map shows the geographic impact of Dalal Aldeghaither's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dalal Aldeghaither with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dalal Aldeghaither more than expected).

Fields of papers citing papers by Dalal Aldeghaither

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dalal Aldeghaither. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dalal Aldeghaither. The network helps show where Dalal Aldeghaither may publish in the future.

Co-authorship network of co-authors of Dalal Aldeghaither

This figure shows the co-authorship network connecting the top 25 collaborators of Dalal Aldeghaither. A scholar is included among the top collaborators of Dalal Aldeghaither based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dalal Aldeghaither. Dalal Aldeghaither is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Aldeghaither, Dalal, et al.. (2022). Modulation of ATP8B1 Gene Expression in Colorectal Cancer CellsSuggest its Role as a Tumor Suppressor. Current Cancer Drug Targets. 22(7). 577–590. 5 indexed citations
2.
Nurunnabi, Mohammad, Norah Almusharraf, & Dalal Aldeghaither. (2020). Mental Health and Well-Being during the Covid-19 Pandemic in Higher Education: Evidence from G20 Countries. Journal of public health research. 9(1_suppl). 2010–2010. 60 indexed citations
3.
Aldeghaither, Dalal, David J. Zahavi, Joseph C. Murray, et al.. (2018). A Mechanism of Resistance to Antibody-Targeted Immune Attack. Cancer Immunology Research. 7(2). 230–243. 34 indexed citations
4.
Aldeghaither, Dalal. (2018). Identifying Molecular Mechanisms of Resistance to Antibody Dependent Cell Mediated Cytotoxicity (ADCC). DigitalGeorgetown (Georgetown University Library). 1 indexed citations
5.
Zahavi, David J., Dalal Aldeghaither, Allison O’Connell, & Louis M. Weiner. (2018). Enhancing antibody-dependent cell-mediated cytotoxicity: a strategy for improving antibody-based immunotherapy. PubMed. 1(1). 7–12. 77 indexed citations
6.
Aldeghaither, Dalal, Joseph C. Murray, Sarah Martinez, et al.. (2017). Induction of tumor cell-based ADCC resistance to create new tumor cell survival and therapy resistance mechanisms.. Journal of Clinical Oncology. 35(7_suppl). 130–130. 1 indexed citations
7.
Menne, Stephan, Daniel B. Tumas, Dalal Aldeghaither, et al.. (2015). Sustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the Woodchuck model of chronic hepatitis B. Journal of Hepatology. 62(6). 1237–1245. 167 indexed citations
8.
Redman, Jason M., Elizabeth Hill, Dalal Aldeghaither, & Louis M. Weiner. (2015). Mechanisms of action of therapeutic antibodies for cancer. Molecular Immunology. 67(2). 28–45. 127 indexed citations
9.
Fletcher, Simon P., Daniel J. Chin, Lore Gruenbaum, et al.. (2015). Intrahepatic Transcriptional Signature Associated with Response to Interferon-α Treatment in the Woodchuck Model of Chronic Hepatitis B. PLoS Pathogens. 11(9). e1005103–e1005103. 36 indexed citations
10.
Aldeghaither, Dalal, Brandon G. Smaglo, & Louis M. Weiner. (2015). Beyond peptides and mAbs—current status and future perspectives for biotherapeutics with novel constructs. The Journal of Clinical Pharmacology. 55(S3). S4–20. 47 indexed citations
11.
Murray, Joseph C., Dalal Aldeghaither, Shangzi Wang, et al.. (2014). c-Abl Modulates Tumor Cell Sensitivity to Antibody-Dependent Cellular Cytotoxicity. Cancer Immunology Research. 2(12). 1186–1198. 12 indexed citations
12.
Smaglo, Brandon G., Dalal Aldeghaither, & Louis M. Weiner. (2014). The development of immunoconjugates for targeted cancer therapy. Nature Reviews Clinical Oncology. 11(11). 637–648. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026